ENROLLED
2015 Regular Session
HOUSE BILL NO. 72
BY REPRESENTATIVE MACK AND SENATOR THOMPSON
1 AN ACT
2 To amend and reenact R.S. 40:964(Schedule I)(F)(12) through (28) and to enact R.S.
3 40:964(Schedule I)(C)(60) through (63) and (E)(10) and (11) and R.S. 40:989.1(F)
4 and 989.2(F), relative to the Uniform Controlled Dangerous Substances Law; to add
5 certain substances to Schedule I of the Uniform Controlled Dangerous Substances
6 Law; to amend provisions of law regarding synthetic cannabinoids; to provide for
7 exceptions for certain dietary supplements; and to provide for related matters.
8 Be it enacted by the Legislature of Louisiana:
9 Section 1. R.S. 40:964(Schedule I)(F)(12) through (28) are hereby amended and
10 reenacted and R.S. 40:964(Schedule I)(C)(60) through (63) and (E)(10) and (11) and R.S.
11 40:989.1(F) and 989.2(F) are hereby enacted to read as follows:
12 §964. Composition of schedules
13 Schedules I, II, III, IV, and V shall, unless and until added to pursuant to R.S.
14 40:962, consist of the following drugs or other substances, by whatever official
15 name, common or usual name, chemical name, or brand name designated:
16 SCHEDULE I
17 * * *
18 C. Hallucinogenic substances. Unless specifically excepted or unless listed
19 in another schedule, any material, compound, mixture, or preparation, which
20 contains any quantity of the following hallucinogenic substances, or which contains
21 any of their salts, isomers, or salts of isomers, whenever the existence of such salts,
22 isomers, or salts of isomers is possible within the specific chemical designation, for
Page 1 of 6
CODING: Words in struck through type are deletions from existing law; words underscored
are additions. HB NO. 72 ENROLLED
1 purposes of this Paragraph only, the term "isomer" includes the optical, position, and
2 geometric isomers:
3 * * *
4 (60) 4-bromo-2,5-dimethoxyphenethylamine (2C-B)
5 (61) N-(2-methoxybenzyl)-2,5-dimethoxy-4-bromophenethylamine
6 (25B-NBOMe)
7 (62) 5-(2-methylaminopropyl)benzofuran (5-MAPB)
8 (63) 4-hydroxy-N-methyl-N-isopropyltryptamine (4-Hydroxy-MIPT)
9 * * *
10 E. Stimulants. Unless specifically excepted, or contained within a
11 pharmaceutical product approved by the United States Federal Food and Drug
12 Administration, or unless listed in another schedule, any material, compound,
13 mixture, or preparation which contains any quantity of the following substances
14 having a stimulant effect on the central nervous system including its salts, isomers,
15 esters, or ethers and salts of isomers, esters, or ethers whenever the existence of such
16 salts, isomers, esters, or ethers and salts of isomers, esters, or ethers is possible
17 within the specific chemical designation:
18 * * *
19 (10) 2-(pyrrolidin-1-yl)-1-(thiophen-2-yl)butan-1-one (Alpha-PBT)
20 (11) 2-(pyrrolidin-1-yl)-1-(thiophen-2-yl)pentan-1-one (Alpha-PVT)
21 F. Synthetic cannabinoids. Unless specifically excepted, or contained within
22 a pharmaceutical product approved by the United States Food and Drug
23 Administration, or unless listed in another schedule, any material, compound,
24 mixture, or preparation, which contains any quantity of a synthetic cannabinoid
25 found to be in any of the following individual compounds or chemical groups, or any
26 of those individual compounds or groups which contain any synthetic cannabinoid
27 salts, isomers, salts of isomers, or nitrogen-heterocyclic analogs, whenever the
28 existence of such salts, isomers, salts of isomers, or nitrogen-heterocyclic analogs
29 is possible within the specific compounds or chemical groups:
30 * * *
Page 2 of 6
CODING: Words in struck through type are deletions from existing law; words underscored
are additions. HB NO. 72 ENROLLED
1 (12) Naphthylamidoindoles: any compound containing a N-(naphthyl)-1H-
2 indole-3-carboxamide structure, whether or not further substituted in the indole ring
3 to any extent or whether or not substituted in the naphthyl ring to any extent.
4 (13) Quinolinylindolecarboxylates: any compound containing a
5 quinolin-8-yl-1H-indole-3-carboxylate or isoquinolin-8-yl-1H-indole-3-carboxylate
6 structure, whether or not further substituted in the indole, ring to any extent or the
7 quinloline, or isoquinoline ring to any extent.
8 (14) Adamantylamidoindoles: Any compound containing a
9 N-(adamantyl)-1H-indole-3-carboxamide structure, whether or not further
10 substituted in the indole ring to any extent or whether or not substituted in the
11 adamantyl ring to any extent.
12 (15) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1-H-
13 indazole-3- carboxamide
14 (16) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1-H-indole-3-
15 carboxamide
16 (17) N- (1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-
17 carboxamide
18 (18)N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-
19 3-carboxamide
20 (19)N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carbo
21 xamide
22 (15) Naphthylindolecarboxylates: Any compound containing a
23 naphthyl-1H-indole-3-carboxylate structure, whether or not further substituted in the
24 indole ring or the naphthyl ring to any extent.
25 (16) Benzylindolecarboxamides: Any compound containing a
26 N-benzyl-1H-indole-3-carboxamide structure, whether or not further substituted in
27 the indole ring or the phenyl ring to any extent.
28 (17) Quinolinylindolecarboxamides: Any compound containing a
29 N-quinolinyl-1H-indole-3-carboxamide or
Page 3 of 6
CODING: Words in struck through type are deletions from existing law; words underscored
are additions. HB NO. 72 ENROLLED
1 N-isoquinolinyl-1H-indole-3-carboxamide structure, whether or not further
2 substituted in the indole, quinoline or the isoquinoline ring to any extent.
3 (18) Phenylindolecarboxamides: Any compound containing a
4 N-phenyl-1H-indole-3-carboxamide structure, whether or not further substituted in
5 the indole ring or the phenyl ring to any extent.
6 (19) Butaldehydeamidoindoles: Any compound containing a
7 N-(1-oxobutan-2yl)-1H-indole-3-carboxamide structure, with or without substitution
8 in the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkoxy, aryl, aryl halide,
9 alkylarylhalide, cycloalkymethyl, cycloalkylethyl, alkenyl, haloalkenyl, aliphatic
10 alcohol, hydroxyl, morpholinoethyl, alkylmorpholinomethyl, alkylpiperidinylmethyl
11 or a tetrahydropyranylmethyl group, whether or not further substituted on the
12 butaldehyde group to any extent.
13 (20) Phenylpropionaldehydeamidoindoles: Any compound containing a
14 N-(1-oxo-3-phenylpropan-2yl)-1H-indole-3-carboxamide structure, with or without
15 substitution in the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkoxy, aryl, aryl
16 halide, alkylarylhalide, cycloalklymethyl, cycloalkylethyl, alkenyl, haloalkenyl,
17 aliphatic alcohol, hydroxyl, morpholinoethyl, alkylmorpholinomethyl,
18 alkylpiperidinylmethyl or a tetrahydropyranylmethyl group, whether or not further
19 substituted on the phenylpropionaldehyde group to any extent.
20 (21) Cumylindolecarboxamides: Any compound containing a
21 N-(2-phenylpropane-2-yl)-1H-indole-3-carboxamide structure, with or without
22 substitution in the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkoxy, aryl, aryl
23 halide, alkylarylhalide, cycloalkymethyl, cycloalkylethyl, alkenyl, haloalkenyl,
24 aliphatic alcohol, hydroxyl, morpholinoethyl, alkylmorpholinomethyl,
25 alkylpiperidinylmethyl or a tetrahydropyranylmethyl group, whether or not further
26 substituted on the phenyl group to any extent.
27 (20)(22) (1-(5-fluoropentyl)-1H-benzimidazol-2-yl)(naphthalen-1-yl)
28 methanone
29 (21)(23) (4-methylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl) methanone
30 (22) Naphthalen-1-yl-1-(4-fluorobenzyl)-1H-indole-3-carboxylate
Page 4 of 6
CODING: Words in struck through type are deletions from existing law; words underscored
are additions. HB NO. 72 ENROLLED
1 (23) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-
2 indazole-3- carboxamide
3 (24) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-
4 indazole-3-carboxamide
5 (25) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-
6 indole-3-carboxamide
7 (26) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-ndole-3-
8 carboxamide
9 (27) Naphthalen-1-yl-1-(5-fluoropentyl)-1H-indole-3-carboxylate
10 (28) N-benzyl-1-pentyl-1H-indole-3-carboxamide
11 (24) 1-(5-fluoropentyl)N-naphthalen-1-yl)-1H-pyrrolo[3,2-c]pyridine-3-
12 carboxamide
13 (25) N-fenchyl-1-[2-(morpholin-4-yl)ethyl]-7-methoxyindole-3-carboxamide
14 (26) naphthalen-1-yl(9-pentyl-9H-carbazol-3-yl)methanone
15 (27) naphthalen-1-yl(9-(5-fluoropentyl)-9H-carbazol-3-yl)methanone
16 (28) 1-methoxy-3,3-dimethyl-1-oxobutanyl-2yl-(1-cyclohexylmethyl)-
17 1H-indazole-3-carboxylate
18 * * *
19 §989.1. Unlawful production, manufacture, distribution, or possession of
20 hallucinogenic plants; exceptions
21 * * *
22 F. The provisions of this Section shall not apply to any dosage form which
23 is labeled as a dietary supplement and is manufactured in compliance with the
24 requirements of sections 402(g)(2), 415 and 761 of the Federal Food, Drug and
25 Cosmetic Act (21 USC 342(g)(2), 350d, 379aa-1).
26 * * *
27 §989.2. Unlawful production, manufacturing, distribution, or possession of
28 prohibited plant products; exceptions
29 * * *
Page 5 of 6
CODING: Words in struck through type are deletions from existing law; words underscored
are additions. HB NO. 72 ENROLLED
1 F. The provisions of this Section shall not apply to any dosage form which
2 is labeled as a dietary supplement and is manufactured in compliance with the
3 requirements of sections 402(g)(2), 415 and 761 of the Federal Food, Drug and
4 Cosmetic Act (21 USC 342(g)(2), 350d, 379aa-1).
5 Section 2. This Act shall become effective upon signature by the governor or, if not
6 signed by the governor, upon expiration of the time for bills to become law without signature
7 by the governor, as provided by Article III, Section 18 of the Constitution of Louisiana. If
8 vetoed by the governor and subsequently approved by the legislature, this Act shall become
9 effective on the day following such approval.
SPEAKER OF THE HOUSE OF REPRESENTATIVES
PRESIDENT OF THE SENATE
GOVERNOR OF THE STATE OF LOUISIANA
APPROVED:
Page 6 of 6
CODING: Words in struck through type are deletions from existing law; words underscored
are additions.